These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17270026)

  • 1. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
    Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
    Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix.
    van Hensbergen Y; Broxterman HJ; Peters E; Rana S; Elderkamp YW; van Hinsbergh VW; Koolwijk P
    Thromb Haemost; 2003 Nov; 90(5):921-9. PubMed ID: 14597989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
    Gao JJ; Xue X; Gao ZH; Cui SX; Cheng YN; Xu WF; Tang W; Qu XJ
    Microvasc Res; 2011 Sep; 82(2):122-30. PubMed ID: 21664364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.
    Bhagwat SV; Lahdenranta J; Giordano R; Arap W; Pasqualini R; Shapiro LH
    Blood; 2001 Feb; 97(3):652-9. PubMed ID: 11157481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
    Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
    Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
    Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
    J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
    Saitoh Y; Koizumi K; Minami T; Sekine K; Sakurai H; Saiki I
    Biol Pharm Bull; 2006 Apr; 29(4):709-12. PubMed ID: 16595904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis.
    Bhagwat SV; Petrovic N; Okamoto Y; Shapiro LH
    Blood; 2003 Mar; 101(5):1818-26. PubMed ID: 12406907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
    Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
    Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
    Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
    Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.
    Kato M; Azuma H; Akaike M; Iuchi T; Aihara K; Ikeda Y; Fujimura M; Yoshida T; Yamaguchi H; Hashizume S; Matsumoto T
    Atherosclerosis; 2005 Nov; 183(1):49-55. PubMed ID: 16216591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model.
    Nakatsu MN; Sainson RC; Pérez-del-Pulgar S; Aoto JN; Aitkenhead M; Taylor KL; Carpenter PM; Hughes CC
    Lab Invest; 2003 Dec; 83(12):1873-85. PubMed ID: 14691306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neridronate inhibits angiogenesis in vitro and in vivo.
    Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
    Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF.
    Ishimoto Y; Hirota-Takahata Y; Kurosawa E; Chiba J; Iwadate Y; Onozawa Y; Hasegawa T; Tamura A; Tanaka M; Kobayashi H
    Cell Physiol Biochem; 2016; 39(5):1905-1918. PubMed ID: 27771716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.
    Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G
    J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells.
    Ma DH; Tsai RJ; Chu WK; Kao CH; Chen JK
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1822-8. PubMed ID: 10393055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a moderate-intensity static magnetic field on VEGF-A stimulated endothelial capillary tubule formation in vitro.
    Okano H; Onmori R; Tomita N; Ikada Y
    Bioelectromagnetics; 2006 Dec; 27(8):628-40. PubMed ID: 16838273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
    Chuang YW; Chang WM; Chen KH; Hong CZ; Chang PJ; Hsu HC
    PLoS One; 2014; 9(5):e95180. PubMed ID: 24879414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.